Dr. Zhao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4500 San Pablo Road S
Jacksonville, FL 32224
Summary
- Dr. Yujie Zhao is an oncologist in Jacksonville, FL and is affiliated with multiple hospitals in the area, including Mayo Clinic Hospital in Florida and St. Vincent's Medical Center Southside. She received her medical degree from Beijing Medical University and has been in practice 23 years. She is experienced in Head and Neck cancer, Lung cancer and Thyroid cancer.
Education & Training
Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Hematology and Medical Oncology, 2008 - 2011- Rutgers Health/Cooperman Barnabas Medical CenterResidency, Internal Medicine, 2005 - 2008
Beijing Medical UniversityClass of 1994
Certifications & Licensure
FL State Medical License 2019 - 2026
IL State Medical License 2015 - 2023
NY State Medical License 2011 - 2017
NJ State Medical License 2008 - 2011
Clinical Trials
- Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery Start of enrollment: 2011 Oct 26
- Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer Start of enrollment: 2013 May 08
- An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026) Start of enrollment: 2014 Mar 27
- Join now to see all
Publications & Presentations
PubMed
- 166 citationsEmerging therapeutic agents for advanced non-small cell lung cancerRuqin Chen, Rami Manochakian, Lauren James, Abdel Ghani Azzouqa, Huashan Shi
Journal of Hematology & Oncology. 2020-05-24 - 21 citationsEmerging Targeted Therapies in Advanced Non-Small-Cell Lung Cancer.Shenduo Li, Guilherme Sacchi de Camargo Correia, Jing Wang, Rami Manochakian, Yujie Zhao
Cancers. 2023-05-24 - 299 citationsThe clinical development of MEK inhibitorsYujie Zhao, Alex A. Adjei
Nature Reviews. Clinical Oncology. 2014-07-01
Authored Content
- Patient referralJanuary 2022
- Provider ProfileJanuary 2022
Press Mentions
New Data Showing That Transgene and NEC’s Individualized Cancer Vaccine TG4050 Induces Strong and Specific Immune Responses Against Tumors Presented at AACR 2023April 18th, 2023- Transgene Presented Additional Phase I Data with TG4050 (Myvac® Platform) at ASCO 2022June 6th, 2022
- Risk Factors for LAAT in Patients with Atrial FibrillationMay 3rd, 2022
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
